WINZOR PHARMACEUTICALS UK LIMITED

Company Registration Number:
07533771 (England and Wales)

Unaudited statutory accounts for the year ended 29 February 2024

Period of accounts

Start date: 1 March 2023

End date: 29 February 2024

WINZOR PHARMACEUTICALS UK LIMITED

Contents of the Financial Statements

for the Period Ended 29 February 2024

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

WINZOR PHARMACEUTICALS UK LIMITED

Directors' report period ended 29 February 2024

The directors present their report with the financial statements of the company for the period ended 29 February 2024

Principal activities of the company

The Company's principle activities continued to be that of export pharmacuticals



Directors

The directors shown below have held office during the whole of the period from
1 March 2023 to 29 February 2024

Mr T Al-Kass
D Al-Kass
T Al-Kass


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
15 September 2024

And signed on behalf of the board by:
Name: Mr T Al-Kass
Status: Director

WINZOR PHARMACEUTICALS UK LIMITED

Profit And Loss Account

for the Period Ended 29 February 2024

2024 2023


£

£
Turnover: 1,578,227 1,917,862
Cost of sales: ( 765,812 ) ( 1,022,364 )
Gross profit(or loss): 812,415 895,498
Administrative expenses: ( 800,167 ) ( 865,088 )
Operating profit(or loss): 12,248 30,410
Profit(or loss) before tax: 12,248 30,410
Tax: ( 2,327 ) ( 1,514 )
Profit(or loss) for the financial year: 9,921 28,896

WINZOR PHARMACEUTICALS UK LIMITED

Balance sheet

As at 29 February 2024

Notes 2024 2023


£

£
Fixed assets
Tangible assets: 3 804,961 804,961
Total fixed assets: 804,961 804,961
Current assets
Stocks: 4 488,324 469,705
Debtors: 5 254,991 290,290
Cash at bank and in hand: 185,758 177,060
Total current assets: 929,073 937,055
Creditors: amounts falling due within one year: 6 ( 77,163 ) ( 117,506 )
Net current assets (liabilities): 851,910 819,549
Total assets less current liabilities: 1,656,871 1,624,510
Creditors: amounts falling due after more than one year: 7 ( 486,258 ) ( 486,258 )
Total net assets (liabilities): 1,170,613 1,138,252
Capital and reserves
Called up share capital: 99 99
Profit and loss account: 1,170,514 1,138,153
Total Shareholders' funds: 1,170,613 1,138,252

The notes form part of these financial statements

WINZOR PHARMACEUTICALS UK LIMITED

Balance sheet statements

For the year ending 29 February 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 15 September 2024
and signed on behalf of the board by:

Name: Mr T Al-Kass
Status: Director

The notes form part of these financial statements

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Financial Reporting Standard 101

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

  • 2. Employees

    2024 2023
    Average number of employees during the period 18 20

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 March 2023 804,961 804,961
Additions
Disposals
Revaluations
Transfers
At 29 February 2024 804,961 804,961
Depreciation
At 1 March 2023
Charge for year
On disposals
Other adjustments
At 29 February 2024
Net book value
At 29 February 2024 804,961 804,961
At 28 February 2023 804,961 804,961

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

4. Stocks

2024 2023
£ £
Stocks 488,324 469,705
Total 488,324 469,705

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

5. Debtors

2024 2023
£ £
Trade debtors 254,991 290,290
Total 254,991 290,290

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

6. Creditors: amounts falling due within one year note

2024 2023
£ £
Trade creditors 77,163 117,506
Total 77,163 117,506

WINZOR PHARMACEUTICALS UK LIMITED

Notes to the Financial Statements

for the Period Ended 29 February 2024

7. Creditors: amounts falling due after more than one year note

2024 2023
£ £
Other creditors 486,258 486,258
Total 486,258 486,258